| Transport and pharmacological properties of nine different human Na, K-ATPase isozymes G Crambert, U Hasler, AT Beggah, C Yu, NN Modyanov, JD Horisberger, ... Journal of Biological Chemistry 275 (3), 1976-1986, 2000 | 522 | 2000 |
| Phospholemman (FXYD1) associates with Na, K-ATPase and regulates its transport properties G Crambert, M Füzesi, H Garty, S Karlish, K Geering Proceedings of the National Academy of Sciences 99 (17), 11476-11481, 2002 | 322 | 2002 |
| Role of β-subunit domains in the assembly, stable expression, intracellular routing, and functional properties of Na, K-ATPase U Hasler, X Wang, G Crambert, P Béguin, F Jaisser, JD Horisberger, ... Journal of Biological Chemistry 273 (46), 30826-30835, 1998 | 185 | 1998 |
| CHIF, a member of the FXYD protein family, is a regulator of Na, K‐ATPase distinct from the γ‐subunit P Béguin, G Crambert, S Guennoun, H Garty, JD Horisberger, K Geering The EMBO journal, 2001 | 184 | 2001 |
| FXYD proteins: new tissue-specific regulators of the ubiquitous Na, K-ATPase G Crambert, K Geering Science's STKE 2003 (166), re1-re1, 2003 | 171 | 2003 |
| FXYD7 is a brain‐specific regulator of Na, K‐ATPase α1–β isozymes P Béguin, G Crambert, F Monnet‐Tschudi, M Uldry, JD Horisberger, ... The EMBO Journal, 2002 | 169 | 2002 |
| FXYD proteins: new tissue‐and isoform‐specific regulators of Na, K‐ATPase K Geering, P Béguin, H Garty, S Karlish, M Füzesi, JD HORISBERGER, ... Annals of the New York academy of sciences 986 (1), 388-394, 2003 | 122 | 2003 |
| Structural and functional interaction sites between Na, K-ATPase and FXYD proteins C Li, A Grosdidier, G Crambert, JD Horisberger, O Michielin, K Geering Journal of Biological Chemistry 279 (37), 38895-38902, 2004 | 106 | 2004 |
| Structural and Functional Features of the Transmembrane Domain of the Na, K-ATPase% Subunit Revealed by Tryptophan Scanning U Hasler, G Crambert, JD Horisberger, K Geering Journal of Biological Chemistry 276 (19), 16356-16364, 2001 | 88 | 2001 |
| Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis J Simonin, E Bille, G Crambert, S Noel, E Dreano, A Edwards, A Hatton, ... Scientific reports 9 (1), 6516, 2019 | 84 | 2019 |
| FXYD3 (Mat-8), a new regulator of Na, K-ATPase G Crambert, C Li, D Claeys, K Geering Molecular biology of the cell 16 (5), 2363-2371, 2005 | 82 | 2005 |
| Electrogenicity of Na, K-and H, K-ATPase activity and presence of a positively charged amino acid in the fifth transmembrane segment M Burnay, G Crambert, S Kharoubi-Hess, K Geering, JD Horisberger Journal of Biological Chemistry 278 (21), 19237-19244, 2003 | 54 | 2003 |
| Increased expression of ATP12A proton pump in cystic fibrosis airways P Scudieri, I Musante, E Caci, A Venturini, P Morelli, C Walter, D Tosi, ... Jci Insight 3 (20), 2018 | 53 | 2018 |
| FXYD7, mapping of functional sites involved in endoplasmic reticulum export, association with and regulation of Na, K-ATPase G Crambert, C Li, LK Swee, K Geering Journal of Biological Chemistry 279 (29), 30888-30895, 2004 | 52 | 2004 |
| Chronic potassium depletion increases adrenal progesterone production that is necessary for efficient renal retention of potassium B Elabida, A Edwards, A Salhi, A Azroyan, H Fodstad, P Meneton, ... Kidney International 80 (3), 256-262, 2011 | 49 | 2011 |
| Regulation of pendrin by pH: dependence on glycosylation A Azroyan, K Laghmani, G Crambert, D Mordasini, A Doucet, A Edwards Biochemical Journal 434 (1), 61-72, 2011 | 46 | 2011 |
| Glucagon actions on the kidney revisited: possible role in potassium homeostasis L Bankir, N Bouby, B Blondeau, G Crambert American Journal of Physiology-Renal Physiology 311 (2), F469-F486, 2016 | 44 | 2016 |
| Regulation of pendrin by cAMP: possible involvement in β-adrenergic-dependent NaCl retention A Azroyan, L Morla, G Crambert, K Laghmani, S Ramakrishnan, ... American Journal of Physiology-Renal Physiology 302 (9), F1180-F1187, 2012 | 41 | 2012 |
| HK-ATPase type 2: relevance for renal physiology and beyond G Crambert American Journal of Physiology-Renal Physiology 306 (7), F693-F700, 2014 | 40 | 2014 |
| New molecular determinants controlling the accessibility of ouabain to its binding site in human Na, K-ATPase α isoforms G Crambert, D Schaer, S Roy, K Geering Molecular Pharmacology 65 (2), 335-341, 2004 | 40 | 2004 |
